Pharma-Bio Serv, Inc.
PBSV
$0.60
-$0.09-13.03%
OTC PK
| 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 10.73M | 10.41M | 12.43M | 12.75M | 12.86M |
| Total Receivables | 2.02M | 2.68M | 2.68M | 2.51M | 2.60M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 415.10K | 327.10K | 418.50K | 442.40K | 474.10K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 13.16M | 13.42M | 15.53M | 15.70M | 15.94M |
|
|
|||||
| Total Current Assets | 13.16M | 13.42M | 15.53M | 15.70M | 15.94M |
| Net Property, Plant & Equipment | 204.30K | 260.50K | 317.10K | 367.90K | 257.40K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 225.60K | 225.60K | 225.60K | 225.60K | 125.60K |
| Total Assets | 13.59M | 13.90M | 16.08M | 16.29M | 16.32M |
|
|
|||||
| Total Accounts Payable | 874.40K | 937.90K | 951.50K | 1.13M | 1.11M |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 71.40K | 113.00K | 154.00K | 165.20K | 161.90K |
| Total Finance Division Other Current Liabilities | 713.20K | 729.30K | 2.31M | 594.30K | 625.00K |
| Total Other Current Liabilities | 713.20K | 729.30K | 2.31M | 594.30K | 625.00K |
| Total Current Liabilities | 1.66M | 1.78M | 3.42M | 1.89M | 1.90M |
|
|
|||||
| Total Current Liabilities | 1.66M | 1.78M | 3.42M | 1.89M | 1.90M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | 28.80K | 71.40K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | 660.90K | 660.90K | 660.90K |
| Total Liabilities | 1.66M | 1.78M | 4.08M | 2.58M | 2.63M |
|
|
|||||
| Common Stock & APIC | 1.68M | 1.67M | 1.66M | 1.65M | 1.64M |
| Retained Earnings | 10.53M | 10.74M | 10.64M | 12.35M | 12.34M |
| Treasury Stock & Other | -284.50K | -282.10K | -304.00K | -285.50K | -294.60K |
| Total Common Equity | 11.93M | 12.12M | 12.00M | 13.72M | 13.69M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 11.93M | 12.12M | 12.00M | 13.72M | 13.69M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 11.93M | 12.12M | 12.00M | 13.72M | 13.69M |
|
|
|||||